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BOTH anaesthetics and surgical trauma could strongly
affect the production of tumour necrosis factor t (TNFt).
During in vitro experiments the authors found that anaes-
thetics modulate the production of TNFt by peripheral
blood mononuclear cells. Notably, Pentothal strongly in-
creased the production ofthe cytokine as compared to both
lipopolysacchride treated and control mononuclear cells,
whereas in supernatants from Leptofen driven mono-
nuclear cells TNFt was strongly reduced. On the other
hand, Pavulon did not significantly affect the cytokine
production. In the in vivo study, in an attempt to
ameliorate the metabolic response to surgical trauma,
L-carnitine was administered to 20 surgical patients, then
the circulating TNFt was measured. The results indicate
that the levels of circulating TNFt were strongly
increased following surgery and that L-carnitine admin-
istration resulted in a strong reduction ofTNFt. Thus, the
data suggest that L-carnitine could be helpful in protecting
surgical patients against dysmetabolism dependent on
dysregulated production of TNFt.
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Introduction
Patients undergoing surgery may subsequently
have life-threatening multiple organ failure
(MOF). The dysregulated release of cytokines by
macrophages is likely to play a major role in
the pathogenesis of this disorder.
2 Among
macrophage derived cytokines, TNF is pivotal
since it is directly involved in mediating the
organism adaptative response to injury, including
surgery.
3,4
Several anaesthetic agents are able to affect the
pattern of cytokine production by monocytes/
macrophages in vitro, including TNF, and
several reports have confirmed that the con-
firmed adminis.tration of anaesthetics, profoundly
derange the normal functions of the immune
system in vivo.5-9
Here, the results of experiments are reported,
which indicate that anaesthetic drugs, most notably
Pentothal, could strongly enhance under in vitro
conditions the TNF production by peripheral
blood mononuclear cells (PBMCs) from healthy
individuals as compared to both lipopolysaccharide
(LPS) treated and control cells. In addition, in in
vivo studies the authors found that serum levels of
TNFo are significantly increased following surgery.
The administration of L-carnitine resulted in the
reduction of circulating TNF.
(C) 1993 Rapid Communications of Oxford ktd
Materials and Methods
In vitro experiments:
PBMCs. PBMCs were obtained from healthy
volunteers by standard methods, as described
previously.
1
Cell cultures. Briefly, PBMCs were resuspended at
the concentration of 2 x 106 cells/ml in RPMI
1640 (Gibco Bio Cult., Paisley, UK) containing 10%
heat-inactivated foetal calf serum, 1% L-glutamine,
and penicillin/streptomycin. PBMCs were cultured
for 72 h in a 5% CO2 atmosphere at 37C in the
presence of either standard LPS concentration, as
described previously
1 or anaesthetic drugs (Lepto-
fen, Pavulon, Pentothal) at the optimal concentra-
tion of 10 #g/ml. At the end of the culture period,
the supernatants were harvested and TNFcz was
measured.
Measurement of TNFz. TNFz was quantified by a
sandwich enzyme immunoassay (Biokine, T Cell
Sciences Inc., MA, USA), according to standard
methods,a The lower limit of TNF0 detection in
this immunoassay was 10pg/ml. Serum TNF
measured in healthy volunteers was below this
limit.
In vivo studies:
Patients. Twenty patients were admitted for
surgery and randomly assigned to receive either
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NLA anaesthesia alone (Group 1) or NLA
anaesthesia plus L-carnitine (CarniteneTM, 1 g
ampoules, Sigma Tau, Pomezia, Italy) (Group 2).
No patient was suffering from cancer or
infections or had received any medical treatment
before the admission to the study. Surgery was
always performed by the same surgeon.
The patients were well matched with respect to
age (45-t-13 and 47 _-q-9 years), weight (71 q-2
and 72_-q-8kg), and height (166_--b24 and
170-t-26 cm), in Group 1 and Group 2, respec-
tively. Surgery was performed because of ne-
phrolithiasis (one and two patients), uterocele (one
and zero), hysteromyoma (one and one), colonic
diverticula (four and five), megacolon (two and
two), and irritable bowel syndrome (one and zero)
in Group 1 and Group 2, respectively. The type of
surgery was colonic resection in three and two,
nephrectomy in one and two, hysterectomy in two
and one, and hemicolectomy in four and five
patients, in Group 1 and Group 2, respectively.
Notably, the duration of surgery was comparable
in both groups (123 _--+- 61 and 139 __+ 52 min in
Group 1 and Group 2, respectively) and the
post-surgery course was not burdened by complica-
tions.
Informed consent was obtained from all subjects
and the study was approved by the Hospital Ethics
Committee on Human Research.
Anaesthetic technique. Premedication was performed
with atropine sulphate (0.5 mg i.m.) and diazepam
(10 mg i.m.) administered 40-50 min before the
scheduled time of surgery. Then, anaesthesia was
induced with droperidol (2.5 mg), fentanyl (0.1 mg)
and thiopentone (3.5 mg/kg). Tracheal intubation
was performed after administering pancuronium
(0.08 mg/kg). Anaesthesia was maintained with 60%
nitrous oxide in oxygen. Supplementary doses of
fentanyl, droperidol, and pancuronium were given
as needed. Mean doses were fentanyl, 0.056 _--k
0.02 mg; pancuronium, 8.3 -q-_ 0.6 mg; droperidol,
3.8 +__ 0.5 mg. At the end of surgery, residual
neuromuscular blockade was antagonized with
a mixture of atropine and neostigmine. All anaes-
thetic drugs were administered by the same
anaesthetist.
Post-surgery care. All patients in both groups were
given buprenorphine 0.3 mg for analgesia on the
day of surgery only.
L-carnitine treatment. In Group 2 patients, L-carnitine
was administered i.v. at the dosage of 8 g at the end
of surgery and 24 h afterwards.
Blood sampling. Samples of peripheral blood were
obtained for TNF measurement on the day before
surgery and 2, 24, and 48 h after surgery (tO, tl, t2,
t3, respectively).
Samples of peripheral blood were obtained for
carnitine measurement at tO, t2, and t3, respectively.
Since the time lag between the end of surgery
(L-carnitine administration) and blood drawing (2 h)
was too short, no samples were collected at tl. In
Group 2 patients, samples of peripheral blood were
obtained before L-carnitine administration.
L-carnitine measurement. Serum levels of carnitines
were measured by using standard methods, as
described previously.
12 Briefly, a neutralized per-
chloric acid extract of plasma was incubated with
14C-acetyl coenzyme A (CoA) in the presence of
carnitine acetyltransferase (CAT). Then, the la-
belled acetyl L-carnitine was separated from the
unreacted 14C-acetyl CoA by an anion exchange
resin and radioactivity counts were measured in the
supernatant. This method allows the quantitative
evaluation of L-carnitine (free carnitine) and
L-carnitine formed from alkaline hydrolysis as an
expression of the total acid soluble L-carnitine.
Short-chain L-carnitine esters were measured as the
difference between total acid soluble I-carnitine and
free L-carnitine.
Statistical analysis: Results are expressed as the
mean + standard deviation. The differences be-
tween groups for paired and unpaired data were
statistically significant for p less than 0.01.
Results
In vitro experiments: The LPS stimulation of PBMCs
proved to strongly increase the TNF0t release in
culture media as compared to unstimulated PBMCs
(p < 0.05), as expected (Fig. 1). However, Pentothal
was significantly more effective with respect to LPS
in inducing TNF synthesis and release by PBMCs
< 0.001) (Fig. 1). The stimulation of PBMCs
with other anaesthetic drugs, such as Pavulon and
Leptofen, did not result in increased TNF
production. In supernatants from Leptofen driven
PBMC cultures TNF levels were strongly reduced
compared to both LPS driven and unstimulated
cultures < 0.05), whereas in supernatants from
Pavulon driven PBMC cultures TNF was similar
to that in unstimulated cultures (Fig. 1).
In preliminary experiments, the addition of
t-carnitine at various doses to anaesthetic driven
PBMC cultures was followed by conflicting effects
on the pattern of TNF production (data not
shown). Further studies to establish both the
optimal dosage and kinetics of adding L-carnitine
to PBMC cultures in order to obtain a clear-cut
modulation of anaesthetic driven TNF production
are therefore needed.
In vivo studies: Patients in Groups 1 and 2 were well
matched for age, weight, height, types and/or
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FIG. 1. TNF levels in supernatants of PBMCs driven by either
anaesthetics (Leptofen, Pavulon, Pentothal) or LPS as well as in
supernatants of unstimulated PBMCs. Anaesthetics were used at the
optimal concentration of 10/g/ml. The results are shown as the mean
levels of TNF of triplicate experiments ___standard deviation. See
Materials and Methods for details.
duration of surgery. During surgery, blood loss
ranged from 600 to 1 200 ml. Nevertheless, patients
did not require blood transfusion and received
conventional crystalloid or colloid (Dextran 70)
fluids. Both Group 1 and Group 2 patients did not
exhibit any complication throughout their course
and the body temperature following surgery did not
exceed 38.2C. The pattern was similar in both
groups. Finally, any treatment related adverse effect
was recorded in patients receiving L-carnitine.
The effects of surgical/anaesthetic trauma on
TNF serum levels are shown in Table 1. At tO, all
patients had circulating TNF within the normal
range. In Group 1, a significant increase of plasma
levels of TNF was found throughout tl
(40_+2pg/ml; p<0.01) to t3 (62___7pg/ml;’
p < 0.001), peaking at t2 (68 _-+ 8 pg/ml; p < 0.001),
with respect to serum levels at tO (5-+-2 pg/ml).
In Group 2 patients strongly increased (p < 0.01)
serum levels of TNF were found only at tl
(30.3 _--k 5 pg/ml) compared to tO (6 2 pg/ml);
at t2 (15+__4pg/ml) and t3 (22+_9pg/ml)
TNF was not significantly different with respect
to tO. Notably, serum levels of TNF were
significantly different between Group 1 and Group
2 patients only at t2 (p < 0.001) and t3 (p < 0.01).
Total, free, and short-chain carnitine levels were
comparable in the two groups and within the
normal range at tO (Table 2). In Group 1 patients,
no significant change of total, free, and short-chain
carnitine was found at t2 and t3 (Table 2). However,
in Group 2 patients serum carnitine levels were
increased significantly at t2 and t3 with respect to
baseline values, as expected (Table 2).
Discussion
The results indicate that anaesthetic drugs can
affect TNF0 production and release by mono-
cytes/macrophages, under in vitro conditions. How-
ever, strong differences exist among anaesthetic
drugs in their ability to modulate TNF produc-
tion, as suggested by the finding that Pentothal
strongly enhanced the cytokine production com-
pared to LPS, whereas both Pavulon and
Leptofen did not. The demonstration that Pentothal
is effective in inducing TNF is consistent with the
hypothesis that surgical patients treated with
Pentothal could be at risk of MOF, since TNF is
Table 2. Total, free, and short-chain carnitine (nmol/ml) in
serum from patients receiving placebo (Group 1) and
L-carnitine (Group 2)
Time Patients
Group Group 2
Table 1. Serum levels of TNF (pg/ml) following surgical/
anaesthetic trauma in patients receiving placebo (Group and
L-carnitine (Group 2)
Time Patients
Group Group 2
tO 5+2 6___2
tl 40 + 2* 30 + 5*
t2 68 8 5 + 4
t3 62 -I- 7**5 22 + 9
p< 0.01 with respect to tO" **p< 0.001 with respect to
tO; ap < 0.001 with respect to Group 2" bp < 0.01 with respect
to group 2. For tO, tl, t2, and t3 see Materials and Methods.
Total carnitine
tO 30 __+ 7 34 + 8
t2 50 + 9 312 + 71
t3 39 + 4 566 + 215*
Free carnitine
tO 34 _+ 7 28 _+ 8
t2 39 _+ 6 291 -I- 72*
t3 28 _+ 8 518 _+ 245*
Short-chain carnitine
tO 6.5 + 3.5 9.7 + 4.8
t2 5.1 +1.9 19_+6"
t3 4.5 ___
2.7 34 -I- 5*
p < 0.001 with respect to both tO and Group 1. For tO, t2, and
t3. See Materials and Methods.
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directly involved in the pathogenesis of the
disorder. However, anaesthetic drugs per se could
also down-modulate the production of TNF, as
shown by Leptofen, or not exhibit any effect at all,
as is the case of Pavulon. Therefore, the
pathophysiological pathways leading to the in-
creased serum levels of TNF following surgery,
which were demonstrated in the in vivo study, may
not be strictly dependent on the immunomodula-
ting properties of the anaesthetic drugs per se.
Further studies are needed to fully understand the
complex network of immune and endocrine events
which account for the increased TNF production
following surgical injury. In fact, the recently
reported ability of benzodiazepines to modulate
IL-1, 1L-6, and TNF synthesis by human
monocytes/macrophages
13 further emphasizes the
complexity of the pathophysiological phenomena
occurring throughout anaesthesia and surgery.
In the patients enrolled in this trial, serum
carnitine levels did not substantially change
following surgery, whereas increased levels were
found in patients receiving L-carnitine, as expected.
In these latter patients, serum TNF was
strongly reduced at t2 and t3 compared to placebo
treated subjects. These preliminary data clearly
suggest that the treatment with L-carnitine could
protect surgical patients against the dysregulated
production of monocyte/macrophage derived cyto-
kines, most notably TNF, which can lead to MOF
and death.
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